Physician profile
Naveed Shafi
NPI 1841266723
$369.11
in general payments reported to CMS, 2019-2025
10 companies · $34.15 in 2025
The $34.15 reported for 2025 was less than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $11.10 · 2021: $15.07 · 2022: $12.98 · 2023: $38.83 · 2024: $80.19 · 2025: $34.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $132.90 | 2019 | |
| Horizon Therapeutics Plc | $64.39 | 2019-2022 | |
| Kerecis Limited | $34.15 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Djo, LLC | $25.02 | 2023 | Cmf |
| Vertex Pharmaceuticals Incorporated | $23.06 | 2024 | |
| Vericel Corporation | $21.98 | 2024 | Maci |
| Wright Medical Technology, INC. | $18.65 | 2019 | |
| Abbott Laboratories | $18.48 | 2024 | Eterna |
| Spinal Simplicity, LLC | $16.67 | 2024 | Ha Minuteman G3-R |
| Bioventus LLC | $13.81 | 2023 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveed Shafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.